Page last updated: 2024-08-21

pyrazines and Coagulation Disorders, Blood

pyrazines has been researched along with Coagulation Disorders, Blood in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Campos, L; Gouveia, CC	1
Eby, C	1
Cook, JJ; Cutrona, KJ; Dorsey, BD; Isaacs, RC; Krueger, JA; Lewis, SD; Lucas, BJ; Lyle, EA; Lynch, JJ; McDonough, CM; Mercer, SP; Michener, MT; Miller-Stein, C; Newton, CL; Wallace, AA; White, RB; Wong, BK	1

Reviews

2 review(s) available for pyrazines and Coagulation Disorders, Blood

Article	Year
Coronavirus Disease 2019: Clinical Review. Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment	2020
Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias. British journal of haematology, 2009, Volume: 145, Issue:2 Topics: Blood Coagulation Disorders; Blood Platelet Disorders; Boronic Acids; Bortezomib; Hemorrhage; Humans; Immunosuppressive Agents; Paraproteinemias; Protease Inhibitors; Pyrazines; Retrospective Studies; Thalidomide; Thrombosis	2009

Article

Year

Coronavirus Disease 2019: Clinical Review.

Acta medica portuguesa, 2020, Jul-01, Volume: 33, Issue:7-8

Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Azithromycin; Betacoronavirus; Blood Coagulation Disorders; China; Chiroptera; Chloroquine; Coronavirus Infections; COVID-19; Glucocorticoids; Humans; Hydroxychloroquine; Infectious Disease Incubation Period; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Prognosis; Pyrazines; Radiography, Thoracic; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Symptom Assessment

2020

Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias.

British journal of haematology, 2009, Volume: 145, Issue:2

Topics: Blood Coagulation Disorders; Blood Platelet Disorders; Boronic Acids; Bortezomib; Hemorrhage; Humans; Immunosuppressive Agents; Paraproteinemias; Protease Inhibitors; Pyrazines; Retrospective Studies; Thalidomide; Thrombosis

2009

Other Studies

1 other study(ies) available for pyrazines and Coagulation Disorders, Blood

Article	Year
P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position. Bioorganic & medicinal chemistry letters, 2011, Mar-01, Volume: 21, Issue:5 Topics: Administration, Oral; Animals; Anticoagulants; Binding Sites; Biological Availability; Blood Coagulation Disorders; Dogs; Drug Design; Molecular Structure; Pyrazines; Rats; Structure-Activity Relationship; Thrombin	2011

Article

Year

P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position.

Bioorganic & medicinal chemistry letters, 2011, Mar-01, Volume: 21, Issue:5

Topics: Administration, Oral; Animals; Anticoagulants; Binding Sites; Biological Availability; Blood Coagulation Disorders; Dogs; Drug Design; Molecular Structure; Pyrazines; Rats; Structure-Activity Relationship; Thrombin

2011